Opexa Therapeutics CEO Invited To Participate In Multiple May Conferences

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, has been invited to join several panel discussions in upcoming conferences in May.

Help employers find you! Check out all the jobs and post your resume.

Back to news